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Abstract
Background: Adherence to self-management recommendations is critical for patients with chronic disease.
Compared to nonsmokers, smokers with conditions such as diabetes, HIV, and heart disease are less likely to adhere
to provider recommendations. Regarding lung disease, asthma and COPD can be caused and/or exacerbated by
smoking, however little is known on the relationship between adherence and smoking status in these patients. The
purpose of this study was to characterize the relationship between smoking status and adherence to multiple
measures of self-care- including medication taking, medication filling, appointment keeping, yearly vaccinations,
carrying medical supplies, and healthcare utilization- in patients with asthma and/or COPD. In addition to smoking
status, we also included an examination of these measures by race/ethnicity, gender, and diagnosis.
Methods: This study employed a cross-sectional design on a convenience sample of n = 84 patients (40–64 years
old) with a diagnosis of asthma and/or COPD. The study was conducted between November 2015 and February
2016 in the waiting rooms of the outpatient pulmonary clinics at the University Medical Center of New Orleans.
Patients completed surveys while awaiting their clinic appointments. Smoking status, gender, race, and diagnosis
were explored as predictors of adherence using descriptive statistics, chi square, and regression analyses.
Results: Compared to nonsmokers, smokers were less adherent to medication filling (p < 0.0001), medication taking
(p = 0.04), and having yearly vaccinations than nonsmokers (p = 0.003). Independent of smoking status, differences
across self-care measures were also found based on respondent diagnosis, race, and gender.
Conclusion: Smoking was associated with lower levels of adherence across multiple measures of self-care. By
identifying self-management practices that are most difficult for smokers to follow, researchers can develop
interventions that target these behaviors. Future studies should further this research by exploring reasons for poor
adherence in smokers as well as address barriers that inhibit self-care.
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Background
Smoking is the leading cause of chronic disease in the
US including 90% of lung cancers, 80% of all chronic
lung conditions, and 20% of all cardiovascular disease
[8]. Asthma and chronic obstructive pulmonary disease
(COPD) affect 8.2% and 6.3% of US adults, respectively.
Nonetheless, although smoking is known to worsen out-
comes for these patients, 25% of asthmatics and 51% of
COPD patients continue to smoke post diagnosis [33].
Compared to non-smokers, smokers with these condi-
tions experience increased hospitalizations, disease-
related complications, and are more likely to die from
their chronic conditions [33].
Poor treatment adherence, a lead contributor to poor
outcomes in some patient groups, is described as a
growing problem in chronic disease literature [28]. Poor
adherence is associated with sociodemographic risk
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factors including low educational attainment, low income
status, race/ethnicity as well as behavioral risk factors
including alcohol abuse, drug use, and tobacco use
[1, 20, 22]. Studies evaluating adherence in smokers
with chronic disease report that tobacco users are
less likely to follow self-management recommenda-
tions than nonsmokers or former smokers [1, 6, 22, 35].
Nonetheless, in these studies, the examination of
treatment adherence is largely limited to the ability
of patients to take medications as prescribed. For
patients with asthma and/or COPD, self-care programs
may include multiple recommendations such as
medication taking, yearly flu and pneumonia vaccina-
tions, carrying medical supplies for sudden exacerba-
tions, reducing or quitting tobacco use, attending
follow-up appointments, or attending pulmonary
rehab. As part of guideline-based care, physicians
may make these and other recommendations for
patients to adopt as part of their self-management
care plan [12, 26].
Although asthma and COPD are caused and/or ex-
acerbated by tobacco use, the relationship between
smoking status and adherence in these patients has
not been previously studied. In this study, researchers
sought to characterize the relationship between smok-
ing and treatment adherence in patients with asthma
and/or COPD. This included an examination of adher-
ence based on several measures of self-care including
medication taking, medication filling, appointment attend-
ance, carrying medical supplies, yearly vaccinations, and
healthcare utilization (i.e., emergency room visits and hos-
pitalizations). In addition to examining adherence in
smokers, researchers also sought to explore additional
patient-level factors including race, gender, and diagnosis.
Methods
Survey instrument
The Asthma and COPD Patient Adherence Survey con-
sisted of 43 Likert and multiple-choice items created by
study researchers and adapted from the Tobacco Control
Initiative Patient Survey [25] and the Medical Outcomes
Survey [17]. The development of new survey items was
informed by clinical practice guidelines for the treatment
of asthma and COPD [12, 26]. The study instrument
was validated using the content validity expert panel re-
view process [21]. Experts (n = 8) in clinical pulmonol-
ogy, allergy, pharmacy, health education, nursing, and
primary care participated in the validation assessment.
Based on content validity index (CVI) methods devel-
oped by Lawshe [21], total survey content validity was
calculated at CVI =0.87, where CVI > 0.80 is acceptable
for inclusion [21]. The survey allowed researchers to col-
lect primary outcome measures of self-reported adher-
ence including medication filling, medication taking,
appointment attendance, carrying medical supplies, yearly
flu and/or pneumonia vaccinations, emergency room
(ER) visits, hospitalizations, and missed appointments
within the past 12 months. Validation and preference of
self-reported adherence is documented in clinical litera-
ture [7, 11, 18]. Patient level factors including demo-
graphic characteristics, tobacco history, and diagnosis
were also collected.
Recruitment and data collection
Approval for this study was obtained from the Institu-
tional Review Board at Louisiana State University Health
Sciences Center and Tulane University School of Medi-
cine (Approval #9138). This study employed a cross-
sectional design on a non-probability, convenience sample
of adult patients (40–64 years old) with asthma and/or
COPD. Patients were excluded if they were unable to
complete the survey on their own. Data collection oc-
curred between November 2015 and February 2016 in the
pulmonary clinic waiting areas of University Medical
Center of New Orleans (UMCNO), a state hospital serv-
ing Louisiana’s indigent population. All patients arriving
for clinic appointments were screened using a two item
query to confirm age and a diagnosis of either asthma-
only (AO), COPD-only (CO), or a combined diagnosis of
asthma and COPD (AC). Eligible patients completed the
survey while waiting for their appointment. The screening
and survey process were anonymous as no patient identi-
fiers were collected. One goal of recruitment was to enroll
an equal number of smokers and nonsmokers into the
study. Study staff disseminated and collected completed
screeners and surveys.
Data analysis
Statistical Analysis Software (SAS) 9.4 was used to
analyze data. Descriptive statistics of patient characteris-
tics including race, gender, medical history, and tobacco
history were performed. Chi square analysis was also
conducted to examine associations among predictors
(i.e., race, gender, diagnosis and smoking status). Bivari-
ate analysis was also performed using chi square analysis
to explore associations between predictors and measures
of adherence. Multivariate logistic regression was con-
ducted to further test predictor effects. Interactions
among predictors were also explored. Odds ratios for
predictors were constructed in order to understand the
direction of relationships.
Results
Sample characteristics
Of the 239 patients screened, 91 (38.1%) were deter-
mined eligible based on age and diagnosis criteria. More
specifically, 62 patients did not meet age criteria (40–64
years), while 86 patients did not have a diagnosis of
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asthma and/or COPD. Of the n = 91 eligible patients, 88
(96.7%) consented to take the survey, and n = 84 com-
pleted the survey in full. Baseline characteristics of the
study sample are reported in Table 1. The age of sam-
pled patients ranged from 41 to 64 years (Mean = 56.07,
SD = 5.25). Respondents were predominately White/
Caucasian (45.1%) and Black/African American (46.3%),
with a small portion identifying as Other (8.4%) which
included Native Hawaiian/Other Pacific Islander (n = 2),
American Indian/Alaskan Native (n = 3), or Hispanic
(n = 2). These participants were combined with Black
participants into one measure “Black and Other Races”
(54.9%). Most patients (91.8%) reported a household
income below 133% of the federal poverty level and
74.7% of respondents had less than a high school dip-
loma or GED.
Smoking history
Participant history of tobacco use is presented in Table 2.
The majority of the sample (62.65%, n = 52) identified as
being “current smokers” (i.e., those who reported smok-
ing 100 cigarettes in their lifetime, and currently smoke).
Respondents who reported smoking 100 cigarettes in
their lifetime but did not currently smoking were de-
fined as former smokers (n = 17). Former smokers and
never smokers (individuals who have never smoked 100
cigarettes in their lifetime) were dichotomized into one
measure, nonsmokers (n = 31), for purposes of this re-
search. Past studies have supported this approach, as
former smokers and never-smokers are behaviorally and
clinically similar in adherence studies [6, 22, 31].
Race, gender and smoking status and diagnosis
Smoking rates were not different between White males
and “Black and Other” males (p = 0.4646). Differences
were also not found between White and “Black and
Other” females. However when comparing “Black and
Other” males to “Black and Other” females, males were
more likely to be smokers (p = 0.056). Regarding patient
diagnosis, current smokers were more likely to have a
combined asthma/COPD (AC) (46.15%) diagnosis, than
COPD-only (CO) (28.85%) or asthma-only (AO)
participants (25.0%).
Analysis of adherence measures and predictors
Associations between adherence measures and predic-
tors are shown in Table 3. When controlling for gender,
smoking status and diagnosis were significant inde-
pendent predictors of medication filling (p = 0.0023 and
p = 0.0008, respectively). Smoking was negatively associ-
ated with having all medications filled, OR = 0.085,
0.018–0.400. AO respondents were more likely to have
all medications filled compared to those patients
with COPD (CO) (p = 0.0005). Patients with asthma
were also more likely than AC patients to have all
medications filled. Smoking status was the only pre-
dictor of taking a medication, as smokers were less
Table 1 Demographic, Medical, and Tobacco Characteristics
(n = 84)
No. (%)
Age M = 56.07 SD = 5.25
Gender
Males 39 46.43%
Females 45 53.57%
Race
White or Caucasian 37 45.12%
Black or African American 38 46.34%
Othera 7 8.54%
Diagnosis
Asthma 27 32.14%
COPD 31 36.90%
Asthma/COPD 26 30.95%
Smoking Statusb
Smokers 52 62.65%
Nonsmokers 31 37.35%
Education Completed
Never attended/Kindergarten only 1 1.27%
Grades 1 through 8 (Elementary) 3 3.80%
Grades 9 through 11 (Some high school) 20 25.32%
Grade 12 or GED (High School Graduate) 35 44.30%
College 1 year to 3 (Some college
or Tech. School)
15 18.99%
College 4 years or more (College graduate) 5 6.33%
Household Incomec
Less than $10,000 16 23.88%
$10,000–14,999 18 26.87%
$15,000–19,999 30 44.78%
$20,000 or more 3 4.48%
Household Sizec M = 2.70 SD = 1.55
% Federal Poverty Levelc
< 100% 36 59.02%
100%–133% 20 32.79%
134%–150% 4 6.56%
> 150% 1 1.64%
NOTE: aNative Hawaiian/Other Pacific Islander, American Indian or Alaskan
Native, those identifying as Hispanic, and Other
bSmoking status: current smokers include those respondents who indicate
smoking 100 cigarettes in their lifetime, and who indicate that they currently
smoke every day or some days. Nonsmokers include those who have never
smoked 100 cigarettes in their lifetime (never smokers) as well as those who
have smoked 100 cigarettes but do not currently smoke (former smokers) and
have not smoked within last 6 months or longer
cIndicates less than 80% response rate for item
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likely to take medications as prescribed compared to non-
smokers (OR = 0.333, 0.1015–0.9320, p = 0.032).
Yearly flu and pneumonia vaccines were independently
predicted by smoking status and diagnosis (p = 0.0085
and p = 0.0016, respectively). Smokers were less likely
to have a flu vaccine than nonsmokers within the
sample (OR = 0.152, 0.444–0.526, p = 0.003). Respon-
dents with AC were more likely to have flu and
pneumonia vaccinations than patients with AO or CO
respondents (OR = 10.399, 2.408–44.915, p = 0.0017).
Race was the only significant predictor of missed
appointments. "Black and Other" respondents were more
likely to miss an appointment than Whites (OR = 4.61,
1.699–12.510, p = 0.0027. Race and diagnosis independ-
ently predicted ER visits (p = 0.0245 and p = 0.0043, re-
spectively), however when controlling for gender, race
and diagnosis also predicted hospital admissions (p =
0.0177 and p = 0.0063, respectively). Whites were more
likely to have ER visits and hospital admissions than
Blacks and Others (OR = 0.133, 0.399–0.449, p = 0.0012
and OR = 0.119, 0.033–0.428, p = 0.0011, respectively).
Diagnosis was also a significant predictor of ER visits and
hospital admissions. Compared to patients with COPD,
patients with asthma were less likely to have an ER
visit (OR = 0.222, 0.058–0.853, p = 0.0285) or be ad-
mitted to the hospital (OR = 0.037, 0.004–0.351, p =
0.004). Differences were not noted in these measures
between patients with AC and CO diagnoses.
Gender was the only significant predictor of medical
appointment attendance as being a female respond-
ent was positively associated with attending medical
appointments (OR = 7.143, 1.452–35.137, p = 0.0156).
Interactions were explored in this analysis however
were not significant.
Discussion
Smoking status and adherence
Reasons for poor medication filling and taking in
smokers may be pharmacological. Inhaled corticoste-
roids (ICS) are commonly prescribed for the daily man-
agement of asthma and COPD. ICS resistance is a
condition that affects smokers, making them less resist-
ant to the therapeutic effects of their ICS medications
[4, 5, 16]. Therefore, if smokers do not feel their medica-
tion is reducing or alleviating symptoms, they may not
fill or take their medications as recommended. Re-
searchers have also investigated poor vaccination efficacy
in smokers, although a consensus has not been deter-
mined in this area [10].
Compared to nonsmokers, smokers may also incur
more health-related costs. Smokers often suffer with
uncontrolled asthma or COPD requiring more costly,
higher dosed therapies that are sometimes not cov-
ered by health plans. Additionally, smokers may feel
less financially stable than nonsmokers due to in-
creased spending on tobacco products [3]. In one
study evaluating tobacco spending in adults, those in-
dividuals with the greatest level of nicotine depend-
ence not only spent the most on cigarettes each
month, but were also more likely to go without their
basic living needs [3].
Flu and pneumonia vaccinations are highly recom-
mended for patients with chronic lung disease as
diseased lungs become less resilient to the effects of
these viruses over time [12, 26]. However, smokers
may be less engaged in their self-care, perhaps even
avoiding preventive and wellness services such as vac-
cinations. This is evident as an association between
active smoking and low adoption of health promoting
behaviors, such as balanced eating and exercise, are
found in the literature [15, 29]. One study even at-
tributed such behavioral differences to varying person-
ality types with smokers being more impulsive, less
agreeable, and less cooperative than nonsmokers [2].
Adherence by race and gender
Compared to males, female respondents were more
likely to attend their asthma and/or COPD related visits
as recommended. Women are often described as better
self-managers of their chronic conditions and report
being more satisfied and engaged with their provider
and care plan [13, 30]. In some studies, women also
expressed a preference to be informed decision makers
of their care and were more likely to play an active role
in physician encounters than men [13, 30].
Table 2 Tobacco Characteristics of the Study Sample (n = 83)
No. (%)
Lifetime Tobacco Usea
Yes 69 83.13%
No 14 16.87%
Current smoking status
Every day 27 32.53%
Some days 25 30.12%
Not at all 31 37.35%
Smoking statusb
Nonsmokers 31 37.35%
Smokers 52 62.65%
Smoking duration (Years) M = 33.05 SD = 10.05
Average cigarettes smoked per day? M = 9.06 SD = 6.66
NOTE: aRespondents who indicated smoking 100 cigarettes in their lifetime
b“Smokers” include those respondents who indicate smoking 100 cigarettes in
their lifetime, and who indicate that they currently smoke every day or some
days. “Nonsmokers” include those who have never smoked 100 cigarettes in
their lifetime (never smokers) as well as those who have smoked 100
cigarettes but do not currently smoke
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Regarding race, Whites in our study had higher ER
visit and hospitalization rates but Blacks and Others
were more likely to miss their appointments. This is
similar to one study describing appointment non-
adherence in a cohort of African American patients with
poorly controlled hypertension [27]. Reasons for missed
appointments in these patients included access to care
as well as poorer knowledge and attitudes towards
care [27]. Although Whites had higher ER visit and
hospitalization rates [24], this may be due to the
group’s ability to recognize symptoms and seek out
immediate care [9]. Additionally, hospital admissions
have even been described as “protective factors”, pos-
sibly even motivating patients to adhere after being
hospitalized [32].
Adherence by diagnosis
Differences in diagnosis were associated with varying
levels of adherence across several measures including
medication filling, ER visits, hospitalizations, carrying
medications, and having a yearly flu and/or pneumonia
vaccination. Excluding vaccinations, patients with an AO
diagnosis had higher levels of adherence across these
measures compared to patients with CO and AC diagno-
ses. Unlike COPD, asthma is non-progressive and symp-
toms are largely reversible with pharmacotherapy [26].
Patients with AO may experience overall fewer symptoms
and can use therapies to quickly alleviate symptoms
compared to those with CO or AC.
Patients with an AO diagnosis may also have less
medication than those with COPD. In one study [19]
those patients with multiple medications were signifi-
cantly less likely to adhere than patients prescribed only
one medication. Depending on level of severity, patients
with COPD may have twice as many medications [12, 26].
Because asthma is largely diagnosed in childhood [26],
asthmatics may also be more accustomed to managing a
chronic lung condition than those with CO which is
Table 3 Race, Gender, Diagnosis and Smoking Status as Predictors of Adherence (n = 82)
Measure Predictors Comparison Groupa OR 95% CI p
Medication Fillingb Smoking Status
Smokers 0.085 0.018–0.400 0.0023
Diagnosis
Asthma 28.628 4.346–188.592 0.0005
AsthmaCOPD 1.323 0.285–6.138 0.7211
Missed Appointments Race
Black & Other Races 4.61 1.699–12.510 0.0027
ER visits Race
Black & Other Races 0.133 0.039–0.449 0.0012
Diagnosis
Asthma 0.278 0.072–1.065 0.0618
AsthmaCOPD 4.315 1.248–14.924 0.0209
Hospital Admissionsb Race
Black & Other Races 0.119 0.33–0.428 0.0011
Diagnosis
Asthma 0.046 0.005–0.442 0.0077
AsthmaCOPD 2.397 0.674–8.522 0.1766
Take a medication (including Inhalers) Smoking Status Smokers 0.333 0.1015–0.9320 0.032
Carrying Medications and Supplies Diagnosis
Asthma 2.2 0.324–4.444 0.1618
AsthmaCOPD 0.273 0.080–0.931 0.013
Yearly Flu Pneumonia Vaccines Smoking Status Smokers 0.152 0.444–0.526 0.003
Diagnosis Asthma 0.73 0.207–2.572 0.6242
AsthmaCOPD 10.399 2.408–44.915 0.0017
Attending Medical Appointmentsc Gender Females 7.143 1.452–35.137 0.0156
NOTE: Significance at p <0.05; Logistic regression performed to identify multiple predictors of adherence
aReference groups for variables include, smoking status = nonsmokers, race =White, gender = male, diagnosis = COPD
bControlling for gender
cControlling for smoking status
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typically diagnosed in late adulthood. Additionally, com-
pared to patients with AO, the progressive nature of
COPD often leads those affected to disability and even
oxygen dependence [12]. These patients may therefore
encounter more physical barriers to self-care than those
managing asthma alone.
Within our sample, patients with a combined diagno-
sis (AC) were more likely to have a vaccination than
those with AO or CO. Patients with this combined diag-
nosis are known to experience more severe symptoms
than those with only asthma or COPD [12]. These pa-
tients may frequent the clinic more often, and therefore
have greater access to preventive services such as
vaccinations.
Limitations
Our study was limited to the use of patient self-reported
data. We therefore lacked information on lung function
in order to confirm diagnoses as well as pharmacy data
to track medication filling. Although research supports
the validity of patient report in measuring adherence
[18], the absence of objective measures does require that
we depend solely on patient’s responses from which to
draw conclusions between smokers and nonsmokers.
Past studies describe an association between smoking and
increased depressive symptoms [14]. Studies also indicate
that depression is a risk factor for poor adherence in
patients with chronic disease [14, 23, 34]). We did not
measure depressive symptoms in our study, however
we acknowledge the potential impact of depression on
self-care.
Conclusion
This was the first study to examine the relationship
between adherence and smoking in patients with asthma
and/or COPD. This was also the first study to examine
adherence in smokers across multiple measures of self-
care in addition to medication taking. Through various
analyses we discovered that some areas of self-care
were not significantly different between smokers and
nonsmokers, however differences did exist by certain
patient-level factors such as respondent gender, race,
and diagnosis.
Results of this study may be used to tailor care for
smokers with asthma and/or COPD. Now that we have
identified areas of poor adherence in this group, clini-
cians may develop targeted interventions such as patient
counseling services to improve medication compliance
and vaccinations in smokers. Investigators may further
this research by examining why differences in adherence
exist between smokers and nonsmokers. For example, a
patient-focused, qualitative study may provide a platform
for smokers to express their treatment preferences as
well as identify barriers they experience which inhibit
their self-care.
Results of this study may also inform the direction of
new clinical research focused on smokers with chronic
disease. Far too often, smokers are excluded from clin-
ical trials for potential therapies or interventions. This
study provides support for the inclusion of smokers in
trials as considerations for poor adherence should be ex-
amined for all patient groups. Being that smokers make
up a substantial proportion of asthma and COPD pa-
tients, their needs should also be considered in the de-
velopment of new therapies.
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